I know, I know, not everyone likes
the OTC Journal selections.
MMED, that the OTC Journal has featured since May 11, remains a very thinly traded stock. Today, it's back to a single trade after a somewhat active Monday session.
From the OTC: "Midas Medici (MMED) is the public company that, until recently, didn't even know it was a public company. They are starting to know, and with this valuation and these numbers, stock buyers are going to start finding out about this one before too long.
You just gotta have a little faith these numbers are going to attract an audience, and it's starting to happen....".
Of course, your due diligence should dictate your actions. Compare the trades before May 11 and the ones after. You can see that trading is starting to, pick up, just a little bit. Do read their recent PRs.
GLTA,
g.p.